Poor survival in stage IIB/C (T4N0) compared to stage IIIA (T1-2 N1, T1N2a) colon cancer persists even after adjusting for adequate lymph nodes retrieved and receipt of adjuvant chemotherapy

[1]  L. Lorenzon,et al.  Sub-staging colorectal cancers and adjuvant treatments. , 2015, Journal of the American College of Surgeons.

[2]  M. Sim,et al.  AJCC Cancer Staging Manual 7th edition criteria for colon cancer: do the complex modifications improve prognostic assessment? , 2013, Journal of the American College of Surgeons.

[3]  Maureen A. Smith,et al.  Adjuvant chemotherapy for stage II colon cancer with poor prognostic features. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  C. Compton,et al.  The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.

[5]  S. Mukherjee,et al.  Adjuvant therapy for completely resected stage II colon cancer. , 2008, The Cochrane database of systematic reviews.

[6]  Quasar Collaborative Group.  Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study , 2007, The Lancet.

[7]  R. Gray,et al.  Randomised trials of HIV prevention , 2007, The Lancet.

[8]  M. Weiser,et al.  Surgical Management of Locally Advanced and Locally Recurrent Colon Cancer , 2005, Clinics in colon and rectal surgery.

[9]  C. Ko,et al.  Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. , 2005, Journal of the National Cancer Institute.

[10]  M. Somerfield,et al.  American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  S. Cha,et al.  Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  T. Lehnert,et al.  Multivisceral Resection for Locally Advanced Primary Colon and Rectal Cancer: An Analysis of Prognostic Factors in 201 Patients , 2002, Annals of surgery.

[13]  S. Marsoni.  Efficacy of adjuvant fluorouracil and leucovorin in stage B2 and C colon cancer. International Multicenter Pooled Analysis of Colon Cancer Trials Investigators. , 2001, Seminars in oncology.

[14]  Carolyn Compton,et al.  American Joint Committee on Cancer prognostic factors consensus conference , 2000, Cancer.

[15]  H. Rockette,et al.  Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04) , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  C. Erlichman.  Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  S B Love,et al.  The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. , 1997, Gastroenterology.

[18]  T R Fleming,et al.  Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  J. P. Pignon,et al.  Efficacy of adjuvant fluorouracil and folinic acid in colon cancer International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators , 1995, The Lancet.

[20]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[21]  J. Park,et al.  Survival Paradox Between Stage IIB/C (T4N0) and Stage IIIA (T1-2N1) Colon Cancer , 2014, Annals of Surgical Oncology.

[22]  L. Sobin,et al.  Re: Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. , 2005, Journal of the National Cancer Institute.

[23]  C. Ko,et al.  Comment on: Colon cancer survival rates with the new american joint committee on cancer sixth edition staging. Authors' reply , 2005 .

[24]  R. Deyo,et al.  ADAPTING A CLINICAL COMORBIDITY USE WITH ICD-g-CM ADMINISTRATIVE INDEX FOR DATABASES , 1992 .

[25]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[26]  E CARBONETTO,et al.  [Colon Cancer]. , 1958, El Dia medico.